Polyester nanomedicines targeting inflammatory signaling pathways for cancer therapy

Sabya Sachi Das1, Sandeep Kumar Singh2, P R P Verma2

  • 1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology - Mesra, Ranchi 835215, Jharkhand, India; School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun 248009, Uttarakhand, India.

Insights

Inflammation significantly impacts cancer growth and treatment. Polyester nanoparticles offer a promising nanotechnology approach to overcome conventional chemotherapy limitations for inflammation-mediated cancers.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Inflammation plays a dual role in cancer progression, influencing tumor growth and therapeutic responses.
  • Key signaling pathways (NF-κB, STAT3) and factors (cytokines, VEGF, TGF-β) regulate inflammation in cancer.
  • Conventional chemotherapeutics face limitations like poor targeting, pharmacokinetics, and toxicity in inflammation-mediated cancers.

Purpose of the Study:

  • To review the therapeutic potential of polyester nanomaterials in targeting inflammation-mediated cancers.
  • To highlight how nanotechnology overcomes conventional chemotherapy drawbacks.
  • To discuss the role of polyester nanoparticles in modulating cancer-related inflammatory pathways.

Main Methods:

  • Literature review focusing on polyester nanomaterials (PLGA, PCL, PLA, PHA) for cancer therapy.
  • Analysis of studies investigating nanoparticle delivery systems for inflammation-mediated cancers.
  • Examination of signaling pathways targeted by these nanocarriers.

Main Results:

  • Polyester nanoparticles demonstrate improved drug delivery, stability, and targetability compared to conventional agents.
  • These systems can protect drugs from degradation and enhance solubility.
  • Nanoparticles reduce cytotoxicity by accumulating in cancer cells, sparing healthy tissues.

Conclusions:

  • Polyester-based nanoparticulate systems show significant therapeutic promise for inflammation-mediated cancers.
  • Nanotechnology offers a viable strategy to enhance the efficacy and safety of cancer therapeutics.
  • Targeting inflammation-related signaling pathways with polyester nanoparticles is a key area for future cancer treatment development.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K